Core Viewpoint - The company has achieved significant growth and performance in 2025, marking a pivotal year in its strategic development and aligning with national economic goals [4][5][6]. Economic Context - In 2025, China's GDP surpassed 140 trillion yuan, growing at a steady rate of 5.0%, providing a solid foundation for future economic endeavors [4]. - The Shanghai Composite Index reached a nearly ten-year high, reflecting positive market sentiment [4]. Company Performance - The company's total asset management scale exceeded 336 billion yuan, demonstrating a historic leap [5]. - Three products achieved top performance in their respective categories: - Rongtong Industry Trend Fund returned 114.61%, outperforming its benchmark by 97.59 percentage points [5][10]. - Rongtong New Energy Fund returned 75.80%, exceeding its benchmark by 57.23 percentage points [5][10]. - Rongtong Stable Trust Fund achieved a return of 39.79%, surpassing its benchmark by 37 percentage points [5][10]. - The company has established a diverse product matrix, including theme ETFs, bond funds, and active equity products, enhancing its service offerings to state-owned enterprises [5]. Strategic Development - The company has undergone a significant systemic transformation over the past three years, accumulating essential institutional, talent, technological, and cultural strengths for long-term growth [6]. - The company aims to balance serving national capital operations with enhancing residents' wealth management [6]. Future Outlook - The year 2025 marks the beginning of the "15th Five-Year Plan" and the 25th anniversary of the company, with a strong belief in the recovery and enhancement of the Chinese economy and capital markets [7]. - The company is committed to sustainable investment performance and aims to contribute to the financial strength of the nation [7].

Group 1 - In 2025, 930 out of 969 comparable ordinary equity funds achieved positive performance, representing 96% of the total, while only 39 funds experienced declines [1] - The top-performing fund, Rongtong Industry Trend Stock, achieved a remarkable return of 114.61%, managed by Li Jin, who has been with Rongtong since 2017 and became a fund manager in 2023 [1] - The fund's top ten holdings in Q3 2025 included stocks from sectors such as optical modules, high-end manufacturing, and biomedicine, with a notable concentration in semiconductor-related stocks in the second half of the year [1] Group 2 - E Fund's Strategic Emerging Industry Stock A and C funds recorded returns of 107.60% and 106.74%, respectively, with top holdings including stocks from Tencent, Alibaba, and Zhongji Xuchuang [2] - The E Fund's Information Industry Selected Stock A and C funds also performed well, with returns of 104.31% and 103.26%, benefiting from the semiconductor sector [2] - Other funds that doubled their performance included Red Soil Innovation New Technology Stock A and Caitong Integrated Circuit Industry Stock A, with returns of 104.91% and 101.46% [2] Group 3 - A total of 14 ordinary equity funds saw returns exceeding 90%, including Huashang High-end Equipment Manufacturing Stock A and Longxin Innovation Driven Stock [3] - Conversely, the biomedicine and consumer sectors lagged significantly, leading to declines of 17.81% and 17.29% for Shenwan Lixin Medical Pioneer Stock A and C [3] - The top holdings of the underperforming funds included various biopharmaceutical companies, indicating a sector-specific weakness [3][4] Group 4 - The underperforming funds, such as Taikang Medical Health Stock A and C, were heavily invested in pharmaceutical stocks, which contributed to their declines of 13.45% and 13.02% [4] - Longxin Consumer Selected Quantitative Stock A and C also faced declines of 12.76% and 12.41%, with a focus on liquor stocks in their top holdings [4]

Group 1: Luxshare Precision Industry Co., Ltd. - The company has developed core capabilities across the entire industrial chain in the humanoid robot sector, capable of independently completing precision machining of key components such as harmonic gears, except for batteries and some joint modules [1] - The automotive business has been established for many years, with a rich product matrix that includes high and low voltage wiring harnesses, high-speed wiring harnesses, special wiring harnesses, and fast-charging guns, all of which have shown good development momentum globally [1] - The company's office is located at No. 313, Beihuan Road, Qingxi Town, Dongguan City, Guangdong Province [1] Group 2: Century Huatong - The games launched in 2023 continue to set new highs, with no observed peak in their lifecycle; Kingshot is breaking overseas records previously set by Whiteout Survival, indicating a larger overseas market with more users [2] - The company has tested multiple products at high speed and low cost, releasing no fewer than 20 products since 2023, with hit products driven by data; approximately two-thirds of total profits come from the "DianDian" segment, which combines cash and equity incentives [2] - The overlap of users in overseas markets is about 20%, and the increase in R&D expenses is due to the expansion of the DianDian team, with minimal impact from dollar conversion [2]

Core Insights - In the first three quarters of this year, 98% of the 976 comparable ordinary equity funds achieved positive performance, with only 23 funds experiencing declines [1] Group 1: Top Performing Funds - The top four performing ordinary equity funds, namely Huaan Pharmaceutical Biotechnology Stock A, Huaan Pharmaceutical Biotechnology Stock C, E Fund Information Industry Select Stock A, and E Fund Information Industry Select Stock C, all saw their performance double, with increases of 103.31%, 102.65%, 102.03%, and 101.26% respectively [1] - Huaan Pharmaceutical Biotechnology Stock's second-quarter report indicates heavy investments in companies such as Innovent Biologics, CSPC Pharmaceutical Group, and others, with significant stock price increases, particularly for 3SBio, which surged over four times [1] - E Fund Information Industry Select Stock's top ten holdings are primarily in the semiconductor sector, including companies like NewEase, Huitian Technology, and Tencent Holdings [1] Group 2: Fund Management and Performance - The E Fund Information Industry Select Stock is managed by Zheng Xi, who has extensive experience in equity investment management and has held various roles within E Fund [2] - Other notable funds such as E Fund Strategic Emerging Industries Stock A and C, and Jiashi Mutual Selection Stock A and C, also reported over 90% increases in the first three quarters [2] - Jiashi Mutual Selection Stock focuses on pharmaceutical stocks, with major holdings in companies like Innovent Biologics and Hengrui Medicine, managed by Hao Miao, who has a strong background in biomedical research [2] Group 3: Underperforming Funds - The fund with the largest decline, Minsheng Jianyin Preferred Stock, fell by 7.39%, primarily investing in blue-chip consumer stocks [4] - The fund's top ten holdings include companies like CATL and BYD, with the current manager, Liu Hao, having less than a year of experience [4] - Other underperforming funds include Changxin Consumer Select Quantitative Stock and Qianhai Kaiyuan Traditional Chinese Medicine Stock, both down by over 5% [4]